An atypical junction of BCR-ABL gene as molelcular marker for quantitative monitoring of minimal residual disease in patients with chronic myeloid leukemia (CML)
| Authors | |
|---|---|
| Year of publication | 2008 |
| Type | Conference abstract |
| MU Faculty or unit | |
| Citation | |
| Description | An atypical junction of BCR-ABL gene as molelcular marker for quantitative monitoring of minimal residual disease in patients with chronic myeloid leukemia (CML). |
| Related projects: |